NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-259-1994-3-US-08 RECOMBINANT POX VIRUS FOR IMMUNIZATION AGAINST TUMOR-ASSOCIATED ANTIGENS US CON 10/197,127 7410644 Expired PDF
NCI E-074-1999-1-US-03 Cyanovirin Conjugates and Matrix-Anchored Cyanovirin and Related Compositions and Methods of Use US DIV 10/197,938 7048935 Expired PDF
NCI E-267-1999-0-US-05 LIGANDS FOR FPR CLASS RECEPTORS THAT INDUCE A HOST IMMUNE RESPONSE TO A PATHOGEN OR INHIBIT HIV INFECTION US National Stage 10/199,228 6808877 Abandoned PDF
NCI E-261-2002-0-US-01 AMIDE-BEARING BENZOLACTAMS THAT MODULATE PROTEIN KINASE C, AND METHOD OF USE THEREOF US 60/395,914 Abandoned
NIDDK E-176-1999-0-US-06 Methanocarba Cycloalkyl Nucleoside Analogues US National Stage 10/169,975 7087589 Expired PDF
NIAID E-129-2003-0-PCT-02 CD25+ Differential Markers and Uses Thereof PCT PCT PCT/US02/22167 Expired
NIAID E-129-2003-0-US-03 ANTIBODIES TO GITR AND USES THEREOF US ORD 10/194,754 Expired
NIAID E-089-1997-4-US-12 Recombinant Parainfluenza Virus Vaccines Attenuated by Deletion or Ablation of a Non-Essential Gene US National Stage 10/030,574 Abandoned
NIAID E-090-2002-0-US-01 ASSAYS FOR ASSEMBLY OF EBOLA VIRUS NUCLEOCAPSIDES Inhibitors of Viral Infection US 60/395,876 Abandoned
NIAID E-188-1992-0-US-09 T CELL RECEPTOR LIGANDS AND METHODS OF USING SAME US CON 10/193,473 6900024 Abandoned PDF
NIAID E-188-1992-0-US-10 T CELL RECEPTOR LIGANDS AND METHODS OF USING SAME US CON 10/193,474 Abandoned
NCI E-200-2002-1-US-01 Persistent HIV-1 Infection of Natural Killer Cells In Patients Receiving Highly Active Antiretroviral Therapy US 60/395,166 Abandoned
NIDDK E-196-2002-0-US-01 Bromotyrosine-Derived Inhibitors of Mycothiol-S-Conjugate Amidase US 60/395,219 Abandoned
NHLBI E-169-1996-2-US-03 METHODS FOR DETECTING INTERMOLECULAR INTERACTIONS IN VIVO AND IN VITRO US DIV 10/191,949 Abandoned
NIA E-247-1997-0-AU-15 HIGHLY SELECTIVE BUTYRYLCHOLINESTERASE INHIBITORS FOR THE TREATMENT AND DIAGNOSIS OF ALZHEIMER'S DISEASE AND DEMENTIAS AU DIV 2002300055 Abandoned
NIMH E-068-2002-0-US-01 SYSTEM FOR IN-VIRTO RECORDING US ORD 10/190,215 Abandoned
NIDCR E-015-2002-3-EP-07 MAMMALIAN SWEET AND AMINO ACID HETERODIMERIC TASTE RECEPTORS EP DIV 11156070.2 Expired
NIDCR E-015-2002-3-EP-05 MAMMALIAN SWEET AND AMINO ACID HETERODIMERIC TASTE RECEPTORS EP National Stage 02749804.7 Expired
NIDCR E-015-2002-3-CA-06 MAMMALIAN SWEET AND AMINO ACID HETERODIMERIC TASTE RECEPTORS CA National Stage 2452716 Expired
NIDCR E-015-2002-1-US-02 Mammalian Sweet And Amino Acid Heterodimeric Taste Receptors US CON 10/190,417 7588900 Issued PDF
NIDCR E-015-2002-3-AU-03 MAMMALIAN SWEET AND AMINO ACID HETERODIMERIC TASTE RECEPTORS AU National Stage 2002320294 Expired
NIDCR E-015-2002-3-PCT-01 MAMMALIAN SWEET AND AMINO ACID HETERODIMERIC TASTE RECEPTORS PCT PCT COMB PCT/US2002/021269 Abandoned
NCI E-255-2001-0-PCT-02 Methods And Compositions For The Diagnosis And Treatment of Cancer, Including Those Involving the Notch Pathway PCT PCT PCT/US02/21344 Expired
NIDDK E-138-1992-1-US-04 METHOD OF TREATING CYSTIC FIBROSIS USING 8-CYCLOPENTYL-1,3-DIPROPYLXAN THINE OR XANTHINE AMINO CONGENERS US CON 10/188,047 Abandoned
NIDCR E-015-2002-3-JP-04 MAMMALIAN SWEET AND AMINO ACID HETERODIMERIC TASTE RECEPTORS JP National Stage 2003-510918 Abandoned
NCI E-159-2004-0-US-01 IMMUNE MODULATORY ACTIVITY OF HUMAN RIBONUCLEASES US 60/393,110 Abandoned
NICHD E-225-1997-9-US-01 Methods For The Production Of Purified Recombinant Human Treatment Of Impaired Lung Function & To Enhance Lyphocyte Production US CIP 10/187,498 Abandoned
NCI E-068-2000-0-US-04 Molecules that Influence Pathogen Resistance US National Stage 10/169,315 Abandoned
NIAID E-178-1999-0-US-12 Production Of Attenuated Human-Bovine Chimeric Respiratory Syncytial Virus Vaccines US National Stage 10/030,951 Abandoned
NHLBI E-211-2002-0-US-01 Il-21 Critically Regulates Immunoglobulin Production US 60/393,215 Abandoned
NCI E-069-2001-0-US-02 Use of Lipoxygenase Inhibitors And PPar Ligands as Anti-Cancer Therapeutic And Intervention Agents US ORD 10/186,070 6756399 Abandoned PDF
NCI E-151-2001-0-PCT-02 Method of Promoting Engraftment of a Donor Transplant in a Recipient Host PCT PCT PCT/US02/20550 Abandoned
NINDS E-143-2002-0-US-01 Method of Treating Autoimmune Diseases with Interferon-Beta and IL-2R Antagonist US 60/393,021 Abandoned
NHLBI E-160-2002-0-US-01 Trypotophan as a Functional Replacement for ADP-ribose-arginine in Recombinant Proteins US 60/393,033 Abandoned
NCI E-262-2000-1-US-01 SH2 DOMAIN BINDING INHIBITORS US 60/392,028 Abandoned
NCI E-013-2002-0-US-01 Humanized Anti-Tag 72 CC49 For Diagnosis And Therapy of Human Carcinoma US 60/393,077 Abandoned
NICHD E-013-2000-0-US-06 PROCESS FOR PREPARING 17alpha-ACETOXY-11beta-(4-N,N-(DIMETHYLAMINO) PHENYL)-21-METHOXY-19-NOREGNA-4,9-DIENE-3,20-DIONE,INTERMEDIATES US National Stage 10/169,139 6768014 Expired PDF
NIAID E-115-2000-0-US-12 Attenuated Human-Bovine Chimeric Parainfluenza Virus (PIV) Vaccines US National Stage 10/030,544 Abandoned
NCI E-114-2001-0-PCT-02 Methods of Generating Human CD4+ Th2 Cells PCT PCT PCT/US02/20415 Expired
NCI E-240-2001-0-PCT-02 Macromolecular Imaging Agents For Liver Imaging PCT PCT PCT/US2002/020118 Expired
NCI E-240-2001-0-EP-03 Macromolecular Imaging Agents For Liver Imaging EP National Stage 02752092.3 Abandoned
NIDDK E-213-2001-2-PCT-01 Vitamin D Receptor Antagonists and Related Compositions and Methods of Use PCT PCT COMB PCT/US02/19774 Expired
NHGRI E-196-2001-0-PCT-02 Use of Interferon-inducible 2',5'-Oligoadenylate-dependent RNase L in The Diagnosis, Prognosis And Treatment of Cancer PCT PCT PCT/US02/19516 Expired
NCI E-059-2001-1-US-01 Transforming Growth Factor Beta(TGF-BETA) Antagonist Selectively Neutralize PATHOLOGICAL TGF BETA. US ORD 10/176,266 Abandoned
NCI E-190-2002-1-US-01 Identification of a Novel BHD Gene US 60/390,291 Abandoned
NCI E-022-1998-0-US-06 ALKENYLDIARYLMETHANE NON-NUCLEOSIDE HIV-1 REVERSE TRANSCRIPTASE INHBIBITORS (NNRTIS) US National Stage 09/581,927 6569897 Abandoned PDF
NCI E-072-1999-0-US-03 Transition Metal Complexes of N ,N',N-Trialkyl-CIS,CIS-1,3,5- Triaminocyclohexane & Related Compositions & Methods of Synthesis... US National Stage 10/049,115 6765104 Abandoned PDF
NCI E-058-2001-0-PCT-02 Human UGRP (Uteroglobin-Related Protein) 1 Promoter And its Use PCT PCT PCT/US02/19456 Expired
NIAID E-122-2001-0-PCT-02 Anti-Arthropod Vector Vaccines,Methods of Selecting and Uses Thereof PCT PCT PCT/US02/19663 Expired
NIAID E-122-2001-0-EP-03 Anti-Arthropod Vector Vaccines, Methods of Selecting and Uses Thereof EP National Stage 02752074.1 Abandoned